Skip to content

Effect of Lower Leg Heating and Transcutaneous Electrical Nerve Stimulation on Exercise Capacity in Patients With PAD

The Acute Effects of Leg Heating and Transcutaneous Electrical Nerve Stimulation on Leg Blood Flow and Functional Capacity in Those With Peripheral Arterial Disease

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03462472
Enrollment
10
Registered
2018-03-12
Start date
2015-11-15
Completion date
2018-06-30
Last updated
2018-03-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Peripheral Arterial Disease

Brief summary

Peripheral arterial disease (PAD) is characterized by poor circulation in the lower extremities that often provokes claudication (leg pain, numbness, and heaviness) with physical exertion. The aim of this research protocol is to determine the effect of two non-invasive treatment modalities on leg blood flow and exercise capacity in those with PAD. Specifically, we are measuring popliteal artery blood flow (Doppler ultrasound), toe oxygen saturation, ankle-brachial index (ABI), and 6-minute walking distance (6MWD) in men and women who have intermittent claudication (Fontaine Stage II; Rutherford Category 1-2) in response to 15 or 45 minutes of lower limb heating and transcutaneous electrical nerve stimulation (TENS).

Interventions

BEHAVIORALLower leg heating

Immersion of lower legs in a circulating water bath at a temperature of 42 degrees Celsius

BEHAVIORALLower leg transcutaneous electrical nerve stimulation (TENS)

Bilateral lower leg transcutaneous electrical nerve stimulation (TENS) using burst mode at a 3Hz burst rate, 100Hz frequency, and 250 µs pulse duration, sufficient to evoke skeletal muscle contraction

Sponsors

Salisbury University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Intermittent claudication (Fontaine Stage II) * Resting ankle-brachial index (ABI) \< 0.90 * Ability to walk \> 60 meters in six minutes

Exclusion criteria

* Body mass index (BMI) \> 35 kg/m2 * Severe exercise limitations (more than PAD) due to co-morbidity * Taking illegal/recreational drugs * Uncontrolled hypertension (\>180/100 mmHg) * Severe peripheral neuropathy * Foot ulcers * Gangrene * Pregnant or breast feeding

Design outcomes

Primary

MeasureTime frameDescription
Distance walked during six-minute walk test35 minutes post-intervention/controlDistance walked during a self-paced six-minute walk

Secondary

MeasureTime frameDescription
Popliteal artery blood flowPre-intervention baseline; 10, 20, and 30 minutes post-intervention/controlUnilateral popliteal blood flow measured via Doppler ultrasound
Time/distance to claudication during six-minute walk35 minutes following each intervention and control periodSubjects give subjective ratings of claudication onset, if applicable, during six-minute walk test
Ankle brachial index (ABI)Pre-intervention baseline and 20 minutes post-intervention/controlSystolic blood pressures (SBP) are measured in the brachial arteries of both arms and in the posterior tibial and dorsalis pedis arteries of both ankles using a hand-held Doppler ultrasound probe and a sphygmomanometer
Toe oxygen saturationPre-intervention baseline; 10, 20, and 30 minutes post-intervention/controlA pulse oximeter is used to measure toe oxygen saturation in the big toe of each of the subject's feet

Countries

United States

Contacts

Primary ContactTom Pellinger, Ph.D.
tkpellinger@salisbury.edu410-677-0144

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026